# uCare.io Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ucare-io-pte

- Industry: Healthcare IT
- Headquarters: Singapore, Singapore
- Website: www.ucare.ai
- Total disclosed funding: $5.5M
- Latest round: Series A (Feb 27, 2019)
- Investors on record: 3

## About

uCare.io Pte. Ltd. is a healthcare technology company that leverages artificial intelligence and machine learning to optimize healthcare processes, enhancing efficiency for patients, payers, and providers.uCare.io Pte. Ltd. was founded in 2016 and is headquartered in Singapore. The company specializes in providing AI-driven healthcare solutions, including the Cost Predictor and Anomaly Detector. Christina Teo serves as both the CEO and the founder, bringing a wealth of experience in healthcare technology. In its funding history, uCare.io raised USD 5.53 mn in its Series A round on February 27, 2019, led by Walden Catalyst, with participation from Great Eastern and WPGrowth Ventures. The company has completed a total of 2 deals, and its current valuation stands at USD 43.456 mn.uCare.io Pte. Ltd. specializes in healthcare technology solutions powered by artificial intelligence and machine learning. The company’s core offerings include a Cost Predictor that provides personalized hospital bill estimates at the point of admission, and an Anomaly Detector that optimizes claims processing by identifying outlier medical claims. These products enhance operational efficiency for insurers and insurance platforms, allowing for early detection of anomalies and facilitating continuous learning of lifetime health risks. The company serves patients, payers, and healthcare providers, with its services deployed across major healthcare institutions in Singapore, including all Parkway Pantai hospitals, while also aiming to expand into sectors such as financial services, food and beverage, and retail.In 2023, uCare.io recorded a revenue of USD 140,754 with an EBITDA of USD -551,921.1. The company operates on a B2B model, forming partnerships with healthcare providers and insurance companies to deliver its AI-driven solutions. Revenue is generated through subscription agreements and service contracts with institutional clients, who benefit from a streamlined claims process and improved cost management. The flagship products, including the Cost Predictor and Anomaly Detector, are central to these agreements, enhancing operational efficiencies and patient care outcomes.uCare.io aims to launch new products designed to further enhance its service offerings within the healthcare sector. The company is also focused on expanding its market reach beyond Singapore, targeting new geographic regions, although specific markets have yet to be disclosed. The recent funding of USD 5.53 mn from the Series A round will be utilized to support these initiatives, enabling the development of innovative solutions and facilitating entry into new sectors. The funding will bolster the company’s strategic growth plans as it seeks to scale its operations.

## Funding rounds

- Series A, Feb 27, 2019, $5.5M — Walden Catalyst, WPGrowth Ventures, Great Eastern

## Investors

- Walden Catalyst (https://capitalatlas.ai/funds/walden-catalyst) — Series A
- WPGrowth Ventures — Series A
- Great Eastern — Series A